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Muscle weakness is commonly seen in individuals after stroke, characterized by lower forces during a maximal volitional
contraction. Accurate quantification of muscle weakness is paramount when evaluating individual performance and response to
after stroke rehabilitation. The objective of this study was to examine the effect of subject-specific muscle force and activation deficits
on predicted muscle coordination when using musculoskeletal models for individuals after stroke. Maximum force generating
ability and central activation ratio of the paretic plantar flexors, dorsiflexors, and quadriceps muscle groups were obtained using
burst superimposition for four individuals after stroke with a range of walking speeds. Two models were created per subject: one with
generic and one with subject-specific activation and maximum isometric force parameters. The inclusion of subject-specific muscle
data resulted in changes in the model-predicted muscle forces and activations which agree with previously reported compensation
patterns and match more closely the timing of electromyography for the plantar flexor and hamstring muscles. This was the first
study to create musculoskeletal simulations of individuals after stroke with subject-specific muscle force and activation data. The
results of this study suggest that subject-specific muscle force and activation data enhance the ability of musculoskeletal simulations
to accurately predict muscle coordination in individuals after stroke.

1. Introduction
Musculoskeletal simulations have the potential to provide
insight into muscle coordination and function for individuals
with gait deficits. Previous musculoskeletal simulations have
shown how muscle coordination can be altered based on
changes in muscle properties [1–4]. A current limitation of
musculoskeletal simulations, however, is that the appropriate muscle properties to use for a specific individual are
unknown. For a particular subject or population (e.g., stroke),
muscle parameters may differ greatly from default model
values, and it has been suggested that selection of muscle
parameters can have a relevant impact on simulation results
[5–7].

Muscle weakness, characterized by lower forces during
a maximal volitional contraction, is a major limiting factor
affecting performance of poststroke gait [8]. The two main
causes of poststroke muscle weakness are disuse atrophy [9]
and impaired muscle activation by the central nervous system
[10]. Studies have shown a reduction in skeletal muscle mass
and an increase in intramuscular fat in the paretic limb
of stroke survivors [9, 11]. Additionally, electromyography
(EMG) has been used to demonstrate activation impairment
in stroke survivors, with measured EMG amplitude lower on
the paretic side muscles compared to the nonparetic side [12].
More recently, studies have used the burst superimposition
technique, which applies electrical stimulation superimposed
over a volitional contraction, to measure subject-specific
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maximum force generation ability and volitional activation
ratio of muscles for healthy and poststroke populations [13–
16].
A study by Xiao and Higginson (2010) explored the sensitivity of a musculoskeletal model to changes in muscle
parameters, showing that predicted muscle forces are sensitive to values of tendon slack length, optimal fiber length,
and differences greater than 10% in maximum isometric force
[3]. Strength deficits seen after stroke are often in excess of
10%, with previous studies reporting paretic side voluntary
moment 80% less than nonparetic force for some individuals
[15–18]. Since variation of muscle properties influences muscle force and coordination, it is possible that the inclusion of
relevant muscle parameters in musculoskeletal models will
lead to more accurate and meaningful results in persons after
stroke.
It has been shown in previous work that model predictions of muscle coordination are altered when muscle
weakness is simulated [1, 4]; however, these studies only
involved randomly imposed weakness to healthy simulations.
To date, no studies have built subject-specific musculoskeletal
models which include experimentally measured values for
muscle weakness from a clinical population such as individuals after stroke. Therefore, the objective of this study
was to examine the effect of subject-specific muscle force
and activation deficits on muscle coordination when using
musculoskeletal models for individuals after stroke. Threedimensional subject-specific musculoskeletal models were
built using experimental gait data from subjects after stroke.
Two simulations were created per subject, one using generic
and one using subject-specific isometric force and maximum
volitional activation model parameters based on experimentally measured data. We hypothesized that subject-specific
activation and muscle force data would result in altered
predicted muscular control patterns that are consistent with
muscle compensation strategies that have been reported in
both modeling and clinical studies. Additionally, we hypothesized that the timing of the subject-specific activations
predicted by the musculoskeletal model would agree better
with the timing of experimentally recorded electromyography measured during gait when subject-specific model
parameters were used.

2. Methods
Four individuals after stroke (65 ± 8 yrs, 9 ± 4 months after
stroke) were recruited to participate in this study. Subjects
were included in this study if they met the following criteria:
6 months after a stroke involving cerebral cortical regions,
being able to walk for 5 minutes at self-selected speed without
a brace or assistive device, passive paretic ankle dorsiflexion
range of motion to reach at least 5∘ of plantar flexion with
the knee flexed, and presence of deficits in walking function.
Subjects were excluded from the study using the following
criteria: severe aphasia, substantial cognitive deficits, cerebellar involvement, or preexisting conditions affecting walking
function [19]. All subjects signed informed consent forms
approved by the Institutional Review Board at the University
of Delaware.
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Table 1: Muscles used for comparison of activation timing between
EMG and model predictions.
EMG muscle
Tibialis anterior
Medial gastrocnemius
Lateral gastrocnemius
Soleus
Lateral hamstrings
Medial hamstrings
Vastus medialis
Vastus lateralis
Rectus femoris

Model muscle
Tibialis anterior
Medial gastrocnemius
Medial gastrocnemius
Soleus
Biceps femoris long head
Biceps femoris long head
Vastus intermedius
Vastus intermedius
Rectus femoris

Kinematic (60 Hz) and kinetic (1080 Hz) gait data were
collected using an 8-camera motion capture system (Motion
Analysis Corp., Santa Rosa, CA, USA) as subjects walked
without a brace or assistive device at their self-selected walking speed on an instrumented split-belt treadmill (Bertec,
Columbus, OH). Kinematics and kinetic data were filtered at
6 Hz. Self-selected walking speed was determined using the
average of three trials of the 6-meter walk test during over
ground walking. Subjects wore an overhead support harness
with no body weight support and were instructed to use
handrails only as necessary.
Electromyography (EMG) data was recorded during the
walking trials. Electrodes were placed on 9 paretic side
muscles by palpation of the muscle bellies (Table 1) and were
tested manually through resisted motion. EMG data were
collected at 1080 Hz and filtered in postprocessing with an 8th
order zero-phase shift low-pass Butterworth filter with a cutoff frequency of 20 Hz high-pass filter. The EMG data were
rectified and then filtered with an 8th order zero-phase shift
low-pass Butterworth filter with a cut-off frequency of 5 Hz.
An eight-order filter was selected as it gave the cleanest signal
for activation onset and offset detection. The EMG data were
normalized to the peak EMG signal from the walking trial
and a representative gait cycle was selected and interpolated
to 100 points.
2.1. Muscle Parameter Testing. Subjects performed the burst
superimposition test to assess the maximum force generating
ability (MFGA) and central activation ratio (CAR) of the
paretic side plantar flexors, dorsiflexors, and quadriceps
muscle groups. Previously developed adjustment equations
were applied to the result of the burst superimposition test to
improve the accuracy and reliability of the test at submaximal
volitional effort [13–15]. For testing of the plantar flexor muscle group, subjects lay supine on a KIN-COM III dynamometer (Chattecx Corp, Chattanooga, Tennessee) with their knee
in extension and ankle at neutral. Velcro straps were used
to hold the foot and shank in position and restraints were
placed on the shoulders of the subject to ensure that all
forces were directed into the transducer and not lost to
body displacement. During the burst superimposition test, an
initial maximal single pulse (600 𝜇s, 135 V) was delivered to
the resting muscle. After this pulse, subjects had five seconds
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to reach their maximum volitional effort. Five seconds after
the first pulse, a maximal electrical stimulation burst (600 𝜇s
pulse duration, 100 ms train duration, 135 V, 100 Hz train) was
delivered while subjects produced their maximum volitional
force. Predicted maximum force generating ability (MFGA),
or the force produced with full muscle activation, using the
burst superimposition test (MFGAburst ) was calculated using
the following equation:
MFGAburst = 𝐹vol + 𝐹stim ,

(1)

where 𝐹vol was the volitional force produced by the subject
and 𝐹stim was the additional force produced by the stimulation. A cubic adjustment was then applied to the MFGA
prediction to account for low levels of volitional activation
[13] when testing the plantar flexor muscles. The level of
volitional muscle activation, called the central activation ratio
(CAR), is calculated as the ratio of volitional force (𝐹vol ) to
the maximum force generating ability of a muscle or muscle
group (MFGA) (2)
CAR =

𝐹vol
,
MFGAburst

(2)

where MFGAburst is the MFGA predicted through the burst
superimposition method used in this study.
Muscle testing was repeated for the dorsiflexors while
laying supine with the ankle at 15∘ of plantar flexion. For
testing of the quadriceps muscle group subjects were seated
upright with their hip at 90 degrees and their knee at 60
degrees. A previously developed adjustment was applied to
the maximal force prediction for the quadriceps [14, 20] to
account for low levels of volitional activation during the test.
2.2. Musculoskeletal Simulations. Two musculoskeletal models were created in OpenSim [21] per subject: one with
generic and one with subject-specific activation and maximum isometric force parameters. The musculoskeletal model
included 54 actuators, with three degrees of freedom at the
pelvis and hip joints and one degree of freedom at the knee,
ankle, and toe joints. The model was scaled to the subject’s
size and mass. Model joint kinematics were determined using
inverse kinematics to determine the model position which
best matches the experimental marker data. Kinematics and
kinetic data were filtered at 6 Hz. Additionally, the residual
reduction algorithm was run to minimize the residual forces
that account for dynamics inconsistencies between kinematic
and kinetic data. Residual and reserve actuators were added
to the model. These actuators account for forces the model
could not resolve with muscle actuators alone. Simulations
were created from heel strike to heel strike of the paretic limb
and all data were reported for the paretic limb. Using the
subject-specific force and activation data obtained through
burst superimposition testing, the maximum isometric force
and maximum activation parameters of the model were set
for the quadriceps (rectus femoris and vastus intermedius),
plantar flexors (soleus, medial gastrocnemius, and tibialis
posterior), and dorsiflexors (tibialis anterior) of the paretic
limb. The maximum activation of each muscle in a muscle

group was set uniformly. For subjects that could not volitionally dorsiflex, the burst superimposition test was not
performed, and a maximum activation of 0.02 was used in the
model, where model activation ranges from 0 to 1. A value
of 0.02 was used because it is the minimum activation the
model will allow. The total isometric force produced by the
group was distributed proportionally to each of the muscles in
the model according to the ratios of the maximum isometric
muscle force within the muscle group in the default model.
Using the computed muscle control (CMC) [22] algorithm in OpenSim [21], the muscle forces and activations
required to reproduce the experimental kinetics and kinematics were calculated. To quantify the difference in muscle
activation between the two models, the average level of activation was calculated over the full gait cycle and during the
double support phase, defined as the period of double support
on the paretic limb during preswing. The double support
phase was chosen as it has been a focus of recent studies
for gait rehabilitation [23] and musculoskeletal modeling of
poststroke gait [24, 25].
Onset and offset of the musculoskeletal model muscle
activations were compared to the onset and offset of EMG
data collected during the walking trial. Visual inspection was
used for determining onsets and offsets of model activation
and EMG data due to poor performance with the highly
variable poststroke EMG data by the traditional threshold
detection method of multiple standard deviations above a
baseline value [26]. Visual inspection was repeated twice
to ensure that the on-/off-times were consistent. For each
point, the graph was zoomed to pick the first point rising/last
point falling during the beginning and end of onset period.
Timing agreement with EMG, defined as the portion of the
gait cycle during which the model-predicted activation was
either on or off at the same time as the EMG, was calculated
for the activation timing of the generic and subject-specific
models. Timing agreement varied from 0 to 1, with a value of 1
indicating complete agreement between the EMG and model
activation.
2.3. Statistical Analysis. Due to the number of subjects in
this study, traditional statistical methods were not applicable.
Instead, we assert that a change of greater than ±0.05 in
activation or greater than ±50 N in force per muscle for
at least three of the four subjects should be considered a
meaningful change as a result of the inclusion of subjectspecific parameters. A change of 0.05 in activation was
based on the minimum level of significant change in model
activation that has been reported in a muscle after a targeted
rehabilitation protocol for individuals after stroke (0.045)
[25]. A 50 N change was also imposed to ensure that the
muscle force was changing in conjunction with an increase
in activation.

3. Results
A total of eight simulations were generated, with simulations
using generic and subject-specific maximum isometric force
and maximum activation parameters created for each of the
four subjects (Table 2).
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Table 2: Subject demographics.

Subject
287
293
313
314

Sex
M
M
M
M

Age (yrs)
63
54
74
67

Weight
91.86
98.67
90.49
81.46

Affected side
L
L
R
L

Time since stroke
7 months
6 months
14 months
9 months

Self-selected walking speed (m/s)
0.18
1.04
0.32
0.65

Table 3: Scaling factors used for maximum isometric force and activation for the subject-specific models.

3.2. Muscle Force. Maximum isometric force was 1.87 ± 0.37
times greater in the quadriceps and 0.24 ± 0.08 times lower
in the plantar flexor muscle group for the subject-specific
model (Table 3). Ten muscles showed changes greater than
50 N in average force for at least three of the four subjects over
either the full gait cycle or double support phase (Figure 2)
when subject-specific muscle parameters were used. The hip
flexors (iliacus, psoas) and knee flexors (biceps femoris long
and short head) showed the largest increase in force (272, 271,
334, and 356 N in double support, resp.), while the plantar
flexors (medial gastrocnemius, tibialis posterior, and soleus)
and dorsiflexors (tibialis anterior) showed the largest decrease
in force over both the full gait cycle and double support
(−1228, −1659, −265, and −1367 N in double support, resp.).
3.3. Muscle Activation Timing. EMG and model activation
timing agreement generally ranged from 0.5 to 0.8 for
the muscles collected. Agreement of model-predicted muscle

Tibialis anterior

Tibialis posterior

314
Activation
0.32
0.23
0.02

Soleus

Medial gastrocnemius

Piriformis

Force
1.63
0.28
1.00

Rectus femoris

Psoas

0.5
0.4
0.3
0.2
0.1
0
−0.1
−0.2
−0.3
−0.4
−0.5
−0.6
−0.7

313
Activation
0.39
0.26
0.02

Iliacus

3.1. Muscle Activation. Maximum activation, as assessed
through CAR, was lower in the subject-specific models
than the generic model for all three muscle groups tested
(quadriceps 0.41 ± 0.14 maximum activation, plantar flexors
0.32 ± 0.20 maximum activations) (Table 3). Twelve muscles
showed changes greater than 0.05 in average activation for at
least three of the four subjects over either the full gait cycle or
double support phase (Figure 1) when subject-specific muscle
parameters were used. The hip flexors (iliacus, psoas) and
knee flexors (biceps femoris short head, sartorius) showed the
greatest increases in activation over both the full gait cycle
and double support phase (0.24, 0.23, 0.33, and 0.21 during
double support, resp.). The knee extensors (rectus femoris),
plantar flexors (medial gastrocnemius, tibialis posterior), and
dorsiflexors (tibialis anterior) showed average decreases in
activation over both the full gait cycle and double support
(−0.21, −0.35, −0.24, and −0.41 over double support, resp.).
Soleus activation increased in the subject-specific models,
compensating for decreased medial gastrocnemius and tibialis posterior activation.

Force
1.49
0.18
1.00

Tensor fasciae latae

293
Activation
0.61
0.61
1.00

Sartorius

Force
2.09
0.33
0.05

Biceps femoris SH

287
Activation
0.32
0.16
0.02

Biceps femoris LH

Knee extensors
Plantar flexors
Dorsiflexors

Force
2.27
0.15
1.00

Change in average activation

Subject

Full gait cycle
Double support

Figure 1: Average change in activation across 4 subjects with
the addition of subject-specific maximum isometric force and
maximum activation parameters for the 12 paretic side muscles with
changes greater than 5% for at least 3 of 4 subjects. Subject-specific
model activation limited to 0.02 for subjects unable to volitionally
dorsiflex during isometric testing.

activation timing with EMG increased for the plantar flexors
(0.06, 0.15, and 0.13, for the medial and lateral gastrocnemius and soleus, resp.) and biceps femoris (0.08) when
subject-specific parameters were used (Figure 3). Agreement
decreased for the tibialis anterior (−0.21) and vastus lateralis
(−0.07) muscles. Decreased agreement of the tibialis anterior
is likely due to subjects’ inability to volitionally dorsiflex
during isometric testing, limiting subject-specific model
activation to 0.02. EMG of the tibialis anterior muscles for
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one subject and lateral hamstrings and vastus lateralis for a
second subject were not used due to poor signal quality.

500
0

4. Discussion

−500
−1000

Tibialis anterior

Tibialis posterior

Soleus

Medial gastrocnemius

Rectus femoris

Psoas

Iliacus

Adductor magnus (int)

−2000

Biceps femoris SH

−1500

Biceps femoris LH

Change in average force (N)

1000

Full gait cycle
Double support

Figure 2: Average change in force across 4 subjects with the addition
of subject-specific maximum isometric force and maximum activation parameters for the 10 paretic side muscles with changes greater
than 50 N for at least 3 of 4 subjects. Int = intermediate.

1

0.9

Timing agreement

0.8
0.7
0.6
0.5
0.4
0.3
0.2

Rectus femoris

Vastus lat.

Vastus med.

Medial hamstrings

Lateral hamstrings

Soleus

Gastrocnemius lat.

Gastrocnemius med.

0

Tibialis anterior

0.1

Genetic
Subject-specific

Figure 3: Timing agreement between EMG and model activation
when using generic or subject-specific muscle parameters for the
nine muscles with EMG collected. Greater value indicates better
timing agreement. Med = medial, Lat = lateral. Subject-specific
model activation limited to 0.02 for subjects unable to volitionally
dorsiflex during isometric testing.

Including subject-specific parameters for maximal force generating ability and activation when using musculoskeletal
models to assess muscle coordination in individuals after
stroke had important implications for model predicted activation, force, and coordination. Nine muscles showed a
change in both average activation and force over double
support or the full gait cycle. Increases were seen in the
activation and force of the hip flexor and knee flexor muscle
groups while decreases were seen in the activation and force
of the knee extensor, plantar flexor, and dorsiflexor muscle
groups when subject-specific muscle parameters were used.
Our experimental results indicate that the subjects in our
study had considerably less plantar flexor and dorsiflexor
maximum force generating ability and volitional activation
than represented by the generic OpenSim muscle properties
(Table 3). Plantar flexor weakness in this study is consistent with previous studies, which show volitional activation
impairment [15–18] and lower maximum force generating
ability [15, 16] in individuals after stroke. Three subjects in
our study exhibited no volitional activation of the dorsiflexors during burst superimposition testing, which supports
findings of inadequate dorsiflexor activation as common
limitation to poststroke gait [12]. Although quadriceps was
less impaired than the dorsiflexors and plantar flexors, its
CAR was still less than CAR reported for older adults [27] and
the maximum force generating ability of the quadriceps was
within the range of previously reported data for older adults
[20].
Previously, model results were shown to be sensitive to
differences greater than 10% in maximum isometric force [3].
With substantial weakness known to occur in individuals
after stroke [16–18] and greater than 80% for some muscles
and subjects in this study, we would expect substantial
differences between the generic and subject-specific models.
Therefore, the changes seen in the model predictions with the
inclusion of subject-specific parameters in this study were not
unexpected.
Recent studies have shown the ability of the hip flexors
and knee flexors to compensate for plantar flexor deficiencies
[4]. Additionally, greater hip flexor activity has been cited
as a compensation seen in individuals following stroke to
overcome plantar flexor weakness [28]. Interestingly, the
changes seen in model predictions with the addition of
subject-specific parameters were consistent with predictions
of muscle compensation strategies by previous model-based
studies with muscle deficits [1, 4]. Increases in knee flexor
activity were also observed in this study and have been
reported previously in response to plantar flexor weakness
[1]. Increased knee flexor activity is likely a compensation for
reduced knee flexion contribution both from the gastrocnemius directly and from induced knee flexion acceleration by
the plantar flexors as a group [29]. It is likely that the decrease
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in rectus femoris activation and force seen in our subjectspecific models is the result of multiple factors. First, there is
a decreased need for contribution to hip flexion by the rectus
femoris because of increased activity of the ipsilateral hip
flexors. Second, there is a reduced need for contribution to
knee extension by the rectus femoris due to reduced opposing
knee flexion generated by the plantar flexors. Overall, the
vastus intermedius activation was very low using both models
(0.05–0.1), with the biarticular rectus femoris being much
more active. As a result, no appreciable change was seen
on average in the activation and force between generic and
subject-specific models.
The activation timing predicted by the model agreed
more closely with EMG for the plantar flexors, biceps
femoris, and rectus femoris when the subject-specific muscle
parameters were used. Increased agreement in the biceps
femoris is noteworthy, as subject-specific parameters were
not used for the hamstrings in the model. This shows that the
inclusion of subject-specific parameters in some muscles can
increase the validity of model predictions for muscles that do
not have subject-specific parameters. In contrast, agreement
of activation timing with EMG for the tibialis anterior
and vastus medialis and lateralis decreased with subjectspecific parameters. It is possible that the poor EMG timing
agreement for the vastii is due to representing the vastii
muscle group together as the vastus intermedius in the model.
Future models which individually model vastii muscles may
show improved agreement with measured EMG timing. Poor
tibialis anterior agreement likely occurred because the tibialis
anterior was constrained to “off ” (0.02 max activation) for
3 of the 4 subject-specific models. EMG signals could still
be measured for the tibialis anterior during gait, however,
despite no volitional activation during the isometric testing,
causing the discrepancy between EMG and model activation.
This suggests that future studies should consider a dynamic
test for assessing dorsiflexor muscle properties in a poststroke
population, as static isometric testing may not capture a
poststroke individual’s capacity to volitionally activate the
dorsiflexors during gait.
An interesting finding which highlights the passive properties of the muscle-tendon unit was seen at the ankle. In our
subjects, there was extreme weakness in the plantar flexors
and dorsiflexors, and during the paretic push-off phase of
gait the model was actually unable to fully generate the joint
torques required using muscle forces alone. As a result of this,
a model “reserve” actuator was needed for the paretic side
ankle joint to generate the rest of the joint torque required,
and for some simulations this reserve actuator torque peaked
between 30 and 50 Nm. The ankle reserve actuator was
needed only for the subject-specific models, which incorporated the weakness measured for our subjects experimentally.
No other reserve actuators contributed meaningful torque in
any of simulations. This is interesting particularly because we
also observed large amounts of baseline or resting plantar
flexor torque when these subjects were undergoing burst
superimposition testing. This suggests that these subjects are
generating a much larger amount of passive force (as was
evident during isometric testing), which would likely play
a significant role during walking, and this may have been
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captured by the model’s reserve actuators. Future studies
should consider quantifying changes in passive muscle and
tendon force and altering modeled muscle properties to more
accurately simulate motion of individuals after stroke.
Subject-specific information in this study was limited
to the maximum force generating ability and maximum
activation of the paretic quadriceps, plantar flexors, and dorsiflexors. Additional muscles and muscle parameters, such
as tendon slack length and optimal fiber length, have been
shown to influence model results [3] and could be considered
in future studies, as they may be influenced by muscle spasticity commonly seen after stroke. The cost function used in our
simulations minimizes the sum of the squares of the muscle
excitations, which is not necessarily appropriate for poststroke gait and may influence the model results. EMG was
not used to constrain the activations predicted by the model
so that we could explore whether model activations predicted
with the addition of subject-specific parameters would match
EMG patterns more closely than the generic model. Muscle
performance was tested in an isometric condition, which may
not precisely represent the activation capacity of an individual
after stroke during a dynamic task such as gait. A limited
sample size of four subjects was used for this study; however,
the subjects included in this study represented a wide range of
function, with self-selected walking speeds ranging from 0.18
to 1.04 m/s. The fact that similar results were found across this
range of walking function indicates that including subjectspecific parameters is important regardless of the magnitude
of functional impairment.
This is the first study to create musculoskeletal simulations of individuals after stroke with subject-specific muscle
force and activation data. The inclusion of subject-specific
muscle data resulted in changes in the model-predicted force
and activation data which agree with previously reported
compensation patterns [1, 4, 28]. Additionally, the timing
of muscle activation predicted by the model agreed more
closely with the timing of EMG for the plantar flexor and
hamstring muscles when subject-specific parameters were
used. The results of this study suggest that subject-specific
isometric force and activation data may affect the accuracy
of model predictions and should be used when building
musculoskeletal models of individuals after stroke.
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